(Q36171871)

12 August 2017

1 reference

title

Multiple sclerosis genetics: leaving no stone unturned (English)

1 reference

12 August 2017

0 references

2

Barcellos LF

1 reference

12 August 2017

1

Oksenberg JR

1 reference

12 August 2017

1 August 2005

1 reference

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

375-387

1 reference

12 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gene.6364237

12 August 2017

0 references

cites work

The prevalence of multiple sclerosis in the world: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

ReviewDoes the “Hygiene Hypothesis” Provide an Explanation for the High Prevalence of Multiple Sclerosis in Sardinia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Age-adjusted recurrence risks for relatives of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

A population-based study of multiple sclerosis in twins: update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The British Isles survey of multiple sclerosis in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Twin concordance and sibling recurrence rates in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Patterns of disease in concordant parent-child pairs with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Identifying disease modifying genes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Modes of action of HLA-DR susceptibility specificities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Multiple sclerosis in the tropics: genetic association to STR's loci spanning the HLA and TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Polymorphisms in the gene encoding thymus-specific serine protease in the extended HLA complex: a potential candidate gene for autoimmune and HLA-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

An integrated haplotype map of the human major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Methods for high-density admixture mapping of disease genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Putative ancestral origins of chromosomal segments in individual african americans: implications for admixture mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

T cells responsive to myelin basic protein in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Microchimerism and HLA relationships of pregnancy: implications for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Microchimerism and HLA-compatible relationships of pregnancy in scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Analysis of IL4R haplotypes in predisposition to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

CD24 is a genetic modifier for risk and progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

High-resolution haplotype structure in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Mapping complex disease loci in whole-genome association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

A common inversion under selection in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Detection of large-scale variation in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

X-inactivation profile reveals extensive variability in X-linked gene expression in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The HLA locus and multiple sclerosis in Sicily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

HLA and prognosis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Cigarette smoking and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Assessment of animal models for MS and demyelinating disease in the design of rational therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Inheritance of susceptibility to experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Large-scale gene-expression studies and the challenge of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Genetical genomics: the added value from segregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Genetics of gene expression surveyed in maize, mouse and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Transcription-based prediction of response to IFNbeta using supervised computational methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Frequencies of the G-protein beta3 subunit C825T polymorphism and the delta 32 mutation of the chemokine receptor-5 in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Association of CCR5 delta32 deletion with early death in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Osteopontin polymorphisms and disease course in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

A population-based study of IL4 polymorphisms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Association of a null mutation in the CNTF gene with early onset of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

αB-Crystallin genotype has impact on the multiple sclerosis phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Association of the APOE epsilon4 allele with disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Apolipoprotein E genotype does not influence the progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Association of APOE polymorphisms with disease severity in MS is limited to women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

A full genome search in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Factors influencing sib risks for Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

Conjugal multiple sclerosis: Population-based prevalence and recurrence risks in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Genetic basis for clinical expression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

A meta-analysis of whole genome linkage screens in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Analysis of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

HLA-DR beta chain residue 86 controls DR alpha beta dimer stability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Association of haplotypes in the beta-chemokine locus with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

HLA and heterogeneity of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

HLA-antigens and the prognosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Natural variation in human gene expression assessed in lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Glutathione S-transferase polymorphisms in MS: their relationship to disability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

A mutated CCR5 gene may have favorable prognostic implications in MS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Osteopontin gene and clinical severity of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

CD95 polymorphisms are associated with susceptibility to MS in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

A Null Mutation in the CNTF Gene Is Not Associated With Early Onset of Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

APOE epsilon2-4 and -491 polymorphisms are not associated with MS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

APOE genotypes and disease severity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364237

7 January 2021

Identifiers

DOI

10.1038/SJ.GENE.6364237

1 reference

12 August 2017

1 reference

PubMed ID

15973459